loader
Please Wait
Applying Filters...
Close
4

Ofichem Header Ofichem Header

X

Annual Sales of 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Revlimid (2)

URL Supplier Web Content
Revlimid
Blood Related Disorders
USD
4,980
5,801
4,980
5,801
821
16%
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Revlimid
Oncology
USD
6,974
5,801
6,974
5,801
1,173
20
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Revlimid
Oncology
USD
8,187
6,974
8,187
6,974
1,213
17
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Revlimid
Oncology
USD
12,106
9,378
12,106
9,378
2,728
29
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Revlimid
Oncology
EURO
70
47
77
52
26
48
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Revlimid
Oncology
USD
12,821
12,106
12,821
12,106
715
6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Revlimid
Oncology
EURO
79
70
83
77
6
8
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Revlimid
Oncology
USD
9,978
12,821
9,978
12,821
-2,843
-22
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Revlimid
Oncology
EURO
76
79
82
83
-1
-4
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Revlimid
Oncology
USD
6,097
9,978
6,097
9,978
-3,881
-39
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY